S. 3770 · 115th Congress
Medicaid Drug Decisions Transparency Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
BookerSponsorNo cosponsors.
This bill expands Medicaid and Medicare reporting requirements related to the transparency of physician ownership or investment interests to include pharmacists and individuals with authority over Medicaid formularies, and also increases civil penalties for violations.
What it does: CRS summary · Introduced in Senate · Dec 18, 2018
Medicaid Drug Decisions Transparency Act
This bill expands Medicaid and Medicare reporting requirements related to the transparency of physician ownership or investment interests to include pharmacists and individuals with authority over Medicaid formularies, and also increases civil penalties for violations.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Medicaid Drug Decisions Transparency Act
Latest action (Dec 18, 2018): Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: Senate · Introduced: Dec 18, 2018
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.